Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Argus Health
Cipla
Queensland Health
Boehringer Ingelheim

Generated: August 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Docket ➤ Sign Up Date Filed 2018-12-19
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties KERYX BIOPHARMACEUTICALS, INC.; PANION & BF BIOTECH, INC.; TEVA PHARMACEUTICAL INDUSTRIES LIMITED; TEVA PHARMACEUTICALS USA, INC.
Patents 7,767,851; 8,093,423; 8,299,298; 8,338,642; 8,609,896; 8,754,257; 8,754,258; 8,846,976; 8,901,349; 9,050,316; 9,328,133; 9,387,191; 9,757,416
Attorneys Anthony David Raucci; David M. Fry; Emily R. Whelan; Jack B. Blumenfeld; Karen Elizabeth Keller; Kevin S. Prussia; Lisa J. Pirozzolo; Nathan Roger Hoeschen; Timothy A. Cook
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 United States Patent Nos. 7,767,851 (the “’851 patent”); 8,093,423 (the “’423 patent”); 8,299,298 (the…(the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896 patent”); 8,754,257 (the “’257…’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent”); 8,901,349 (the “’349 patent…25 PageID #: 2 patent”); 9,328,133 (the “’133 patent”); 9,387,191 (the “’191 patent”); and 9,757,416… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C External link to document
2019-04-10 17 Complaint - Amended United States Patent Nos. 7,767,851 (the “’851 patent”); 8,093,423 (the “’423 patent”); 8,299,298 (the…(the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896 patent”); 8,754,257 (the “’257…’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent”); 8,901,349 (the “’349 patent9,050,316 (the “’316 patent”); 9,328,133 (the “’133 patent”); and 9,757,416 (the “’416 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Farmers Insurance
Covington
US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.